Combined hepatocellular-cholangiocarcinoma (CHC) is a rare primary tumor of the liver. Histologically, it comprises components of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) but is associated with a worse prognosis. International guidelines regarding its management are scarce, with surgical management (major hepatectomy) being the treatment of choice. In this report, we present a challenging case of a 73-year-old male with primary CHC who was not a surgical candidate but underwent hepatic artery radioembolization instead.
Keywords: cholangiocarcinoma; combined hepatocellular-cholangiocarcinoma; hepatocellular carcinoma (hcc); liver tumor; trans-arterial radioembolization.
Copyright © 2021, Ayas et al.